AU9185598A - Novel neuropeptide y receptor antagonists - Google Patents

Novel neuropeptide y receptor antagonists

Info

Publication number
AU9185598A
AU9185598A AU91855/98A AU9185598A AU9185598A AU 9185598 A AU9185598 A AU 9185598A AU 91855/98 A AU91855/98 A AU 91855/98A AU 9185598 A AU9185598 A AU 9185598A AU 9185598 A AU9185598 A AU 9185598A
Authority
AU
Australia
Prior art keywords
receptor antagonists
novel neuropeptide
neuropeptide
novel
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91855/98A
Inventor
Takehiro Fukami
Takahiro Fukuroda
Masaki Ihara
Akio Kanatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU9185598A publication Critical patent/AU9185598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU91855/98A 1997-09-25 1998-09-25 Novel neuropeptide y receptor antagonists Abandoned AU9185598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27812097 1997-09-25
JP9-278120 1997-09-25
PCT/JP1998/004314 WO1999015516A1 (en) 1997-09-25 1998-09-25 Novel neuropeptide y receptor antagonists

Publications (1)

Publication Number Publication Date
AU9185598A true AU9185598A (en) 1999-04-12

Family

ID=17592902

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91855/98A Abandoned AU9185598A (en) 1997-09-25 1998-09-25 Novel neuropeptide y receptor antagonists

Country Status (2)

Country Link
AU (1) AU9185598A (en)
WO (1) WO1999015516A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288122C (en) 1997-04-23 2006-09-26 Banyu Pharmaceutical Co., Ltd. Neuropeptide y receptor antagonist
US7745216B2 (en) 1999-02-10 2010-06-29 Curis, Inc. Methods and reagents for treating glucose metabolic disorders
DE60045030D1 (en) 1999-02-10 2010-11-11 Curis Inc PEPTIDE YY (PYY) FOR THE TREATMENT OF GLUCOSE METABOLISM DISEASES
WO2002047712A2 (en) 2000-12-14 2002-06-20 Amylin Pharmaceuticals, Inc. Peptide yy and peptide yy agonists for treatment of metabolic disorders
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
EA008829B1 (en) 2002-12-17 2007-08-31 Нэстек Фармасьютикал Кампани Инк. Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
US7186692B2 (en) 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
WO2005077094A2 (en) 2004-02-11 2005-08-25 Amylin Pharmaceuticals, Inc. Pancreatic polypeptide family motifs and polypeptides comprising the same
CN101277960A (en) 2005-09-29 2008-10-01 默克公司 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
EP2083831B1 (en) 2006-09-22 2013-12-25 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
AU2009308980B2 (en) 2008-10-30 2013-02-28 Merck Sharp & Dohme Corp. Isonicotinamide orexin receptor antagonists
AR088352A1 (en) 2011-10-19 2014-05-28 Merck Sharp & Dohme ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE
WO2014061764A1 (en) * 2012-10-19 2014-04-24 第一三共株式会社 Xanthene derivative
WO2020167706A1 (en) 2019-02-13 2020-08-20 Merck Sharp & Dohme Corp. 5-alkyl pyrrolidine orexin receptor agonists
US20230018413A1 (en) 2019-08-08 2023-01-19 Merck Sharp & Dohme Corp. Heteroaryl pyrrolidine and piperidine orexin receptor agonists
JP7443625B2 (en) 2020-08-18 2024-03-05 メルク・シャープ・アンド・ドーム・エルエルシー Bicycloheptane pyrrolidine orexin receptor agonist

Also Published As

Publication number Publication date
WO1999015516A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU7079498A (en) Neuropeptide y receptor antagonist
AU2242197A (en) Benzimidzolyl neuropeptide y receptor antagonists
AU3953795A (en) Bicyclic neuropeptide y receptor antagonists
AU6144098A (en) Amide derivatives as selective neuropeptide y receptor antagonists
AU3579897A (en) Fibrinogen receptor antagonists
AU7692996A (en) Receptor antagonists
IL120724A0 (en) Indolyl neuropeptide Y receptor antagonists
AU1251597A (en) Cosmetic composition containing a neuropeptide Y receptor antagonist
AU6267198A (en) Amides as npy5 receptor antagonists
AU4746297A (en) Vitronectin receptor antagonists
IL133430A0 (en) 4-AMINOPYRROLE (3, 2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
AU8689798A (en) Integrin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
AU5577096A (en) Sulfonylquinolines as neuropeptide y1 antagonists
AU1553199A (en) Antagonists of g-protein-coupled receptor
PL339617A1 (en) Novel antagonists of neuropeptide y
AU8673198A (en) Il-8 receptor antagonists
AU9185598A (en) Novel neuropeptide y receptor antagonists
HK1031726A1 (en) Thrombin receptor antagonists
AU7132898A (en) Edg-1-like receptor
EP0809648A4 (en) Neuropeptide y receptor
GB9523999D0 (en) Indolyl neuropeptide y receptor antagonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
AU1535699A (en) Novel receptors opg-2
AU6435098A (en) Il-8 receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase